Ilaria Imarisio

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 210 citations · Full text

Medicine, Oncology, Pharmacology +16

Nutritional counseling with or without systematic use of oral nutritional supplements in head and neck cancer patients undergoing radiotherapy

Emanuele Cereda, Silvia Cappello, Sara Colombo et al. · Radiotherapy and Oncology · 2017 · 168 citations

Agriculture, Oncology, Radiation Oncology +17

Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib

Camillo Porta, Chiara Paglino, Mara De Amici et al. · Kidney International · 2010 · 99 citations · Full text

Medicine, Oncology, Pharmacology +16

Sequential use of sorafenib and sunitinib in advanced renal‐cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases

Camillo Porta, Giuseppe Procopio, Giacomo Cartenì et al. · British Journal of Urology · 2011 · 87 citations

Medicine, Oncology, Pharmacotherapy +16

Changes in Circulating Pro-Angiogenic Cytokines, other than VEGF, before Progression to Sunitinib Therapy in Advanced Renal Cell Carcinoma Patients

Camillo Porta, Chiara Paglino, Ilaria Imarisio et al. · Oncology · 2012 · 78 citations

Medicine, Oncology, Pharmacology +17